Yalcinkaya C - Search Results

1

Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.

Gulec B, Kurucu H, Bozbay S, Dikmen Y, Sayman H, Tuzun E, Tutuncu M, Uygunoglu U, Yalcinkaya C, Saip S, Siva A. Gulec B, et al. Among authors: yalcinkaya c. Mult Scler Relat Disord. 2020 Jul;42:102075. doi: 10.1016/j.msard.2020.102075. Epub 2020 Apr 30. Mult Scler Relat Disord. 2020. PMID: 32388459 Review.

2

MRI findings in pediatric neuro-Behçet's disease.

Saltik S, Saip S, Kocer N, Siva A, Yalçinkaya C. Saltik S, et al. Among authors: yalcinkaya c. Neuropediatrics. 2004 Jun;35(3):190-3. doi: 10.1055/s-2004-815826. Neuropediatrics. 2004. PMID: 15248102

3

Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.

Uygunoglu U, Gunduz A, Menku SF, Yilmaz B, Hatipoglu E, Yalcinkaya C, Saip S, Apaydin H. Uygunoglu U, et al. Among authors: yalcinkaya c. Cerebellum. 2014 Dec;13(6):787-90. doi: 10.1007/s12311-014-0587-y. Cerebellum. 2014. PMID: 25084753 No abstract available.

4

Prenatal unilateral cerebellar hypoplasia diagnosed as PHACE syndrome.

Erturk O, Uygunoglu U, Celkan T, Yalcinkaya C. Erturk O, et al. Among authors: yalcinkaya c. Childs Nerv Syst. 2016 Apr;32(4):587-8. doi: 10.1007/s00381-016-3027-0. Epub 2016 Jan 29. Childs Nerv Syst. 2016. PMID: 26825811 No abstract available.

5

Identification of 3 Novel Patients with CLCN2-Related Leukoencephalopathy due to CLCN2 Mutations.

Zeydan B, Uygunoglu U, Altintas A, Saip S, Siva A, Abbink TEM, van der Knaap MS, Yalcinkaya C. Zeydan B, et al. Among authors: yalcinkaya c. Eur Neurol. 2017;78(3-4):125-127. doi: 10.1159/000478089. Epub 2017 Jul 26. Eur Neurol. 2017. PMID: 28746943 Free article. No abstract available.

6

Analysis of determinants of treatment change in adult paediatric-onset MS patients.

Güleç ZEK, Uygunoğlu U, Tütüncü M, Saip S, Siva A, Yalçınkaya C. Güleç ZEK, et al. Among authors: yalcinkaya c. Mult Scler Relat Disord. 2023 Jan;69:104463. doi: 10.1016/j.msard.2022.104463. Epub 2022 Dec 21. Mult Scler Relat Disord. 2023. PMID: 36563594

7

Ocrelizumab in pediatric multiple sclerosis.

Bibinoğlu Amirov C, Saltık S, Yalçınkaya C, Tütüncü M, Saip S, Siva A, Uygunoğlu U. Bibinoğlu Amirov C, et al. Among authors: yalcinkaya c. Eur J Paediatr Neurol. 2023 Mar;43:1-5. doi: 10.1016/j.ejpn.2023.01.011. Epub 2023 Jan 27. Eur J Paediatr Neurol. 2023. PMID: 36724688

8

Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex.

Kilincaslan A, Kok BE, Tekturk P, Yalcinkaya C, Ozkara C, Yapici Z. Kilincaslan A, et al. Among authors: yalcinkaya c. J Child Adolesc Psychopharmacol. 2017 May;27(4):383-388. doi: 10.1089/cap.2016.0100. Epub 2016 Oct 31. J Child Adolesc Psychopharmacol. 2017. PMID: 27797585

9

ADCY5 gene mutation: a case report.

Tezen D, Gunduz A, Erdemir Kiziltan M, Yalcinkaya C, Kiziltan G. Tezen D, et al. Among authors: yalcinkaya c. Neurol Sci. 2022 Dec;43(12):6947-6950. doi: 10.1007/s10072-022-06394-0. Epub 2022 Sep 16. Neurol Sci. 2022. PMID: 36112278

10

Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey.

Ertan S, Uluduz D, Ozekmekçi S, Kiziltan G, Ertan T, Yalçinkaya C, Ozkara C. Ertan S, et al. Among authors: yalcinkaya c. Mov Disord. 2009 Apr 15;24(5):759-62. doi: 10.1002/mds.22114. Mov Disord. 2009. PMID: 19205065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page